Clinical significance of electrocardiographic markers of myocardial damage prior to aortic valve replacement.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 05 2020
Historique:
received: 02 07 2019
revised: 13 01 2020
accepted: 28 01 2020
pubmed: 19 2 2020
medline: 31 5 2022
entrez: 19 2 2020
Statut: ppublish

Résumé

Pre-operative myocardial fibrosis and remodeling impact on outcomes after aortic valve replacement (AVR). We aimed at investigating the prognostic impact of preoperative electrocardiographic (ECG) markers of left ventricular (LV) myocardial damage, i.e. bundle branch block (BBB) and ECG strain pattern after (surgical or transcatheter) AVR for severe aortic stenosis (AS). Between April 2008 and October 2017, we explored consecutive patients referred to our Heart Valve Clinic for first AVR for severe AS. Detailed pre-operative phenotyping and ECG analysis were performed. Patients were followed-up after AVR for major cardiac events (ME), i.e. cardiovascular death, cardiac hospitalization for acute heart failure and stroke. BBB and ECG strain were respectively observed in 13.5 and 21% of the 1122 patients included. These ECG markers identified a subgroup of older patients, with higher NYHA class and more advanced myocardial disease as detected by echocardiography, i.e. higher LV mass and lower LV ejection fraction, global longitudinal strain and integrated backscatter, than patients without ECG strain or BBB. ME occurred in 212 (18.6%) patients during a mean follow-up of 4.4 ± 1.5 years with higher incidence in case of ECG strain or BBB (HR 1.56, 95%CI 1.13-2.14, p = 0.006; HR 1.47, 95%CI 1.02-2.13, p = 0.04 respectively). The prognostic value of ECG strain remained significant after adjustment for age, diabetes and pre-operative LVEF. Pre-operative ECG markers of myocardial damage identify a subgroup of AS patients at high risk of post-AVR cardiovascular complications irrespective of other prognostic factors and should help the multiparametric staging of cardiac damage to guide AVR.

Sections du résumé

BACKGROUND
Pre-operative myocardial fibrosis and remodeling impact on outcomes after aortic valve replacement (AVR). We aimed at investigating the prognostic impact of preoperative electrocardiographic (ECG) markers of left ventricular (LV) myocardial damage, i.e. bundle branch block (BBB) and ECG strain pattern after (surgical or transcatheter) AVR for severe aortic stenosis (AS).
METHODS
Between April 2008 and October 2017, we explored consecutive patients referred to our Heart Valve Clinic for first AVR for severe AS. Detailed pre-operative phenotyping and ECG analysis were performed. Patients were followed-up after AVR for major cardiac events (ME), i.e. cardiovascular death, cardiac hospitalization for acute heart failure and stroke.
RESULTS
BBB and ECG strain were respectively observed in 13.5 and 21% of the 1122 patients included. These ECG markers identified a subgroup of older patients, with higher NYHA class and more advanced myocardial disease as detected by echocardiography, i.e. higher LV mass and lower LV ejection fraction, global longitudinal strain and integrated backscatter, than patients without ECG strain or BBB. ME occurred in 212 (18.6%) patients during a mean follow-up of 4.4 ± 1.5 years with higher incidence in case of ECG strain or BBB (HR 1.56, 95%CI 1.13-2.14, p = 0.006; HR 1.47, 95%CI 1.02-2.13, p = 0.04 respectively). The prognostic value of ECG strain remained significant after adjustment for age, diabetes and pre-operative LVEF.
CONCLUSIONS
Pre-operative ECG markers of myocardial damage identify a subgroup of AS patients at high risk of post-AVR cardiovascular complications irrespective of other prognostic factors and should help the multiparametric staging of cardiac damage to guide AVR.

Identifiants

pubmed: 32067832
pii: S0167-5273(19)33328-5
doi: 10.1016/j.ijcard.2020.01.073
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

130-135

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest No disclosures to declare.

Auteurs

Augustin Coisne (A)

CHU Lille, Department of Clinical Physiology and Echocardiography, France; Univ. Lille, U1011 - EGID, F-59000 Lille, France; Inserm, U1011, F-59000 Lille, France; Institut Pasteur de Lille, F-59000 Lille, France. Electronic address: augustin.coisne@chru-lille.fr.

Sandro Ninni (S)

Univ. Lille, U1011 - EGID, F-59000 Lille, France; Inserm, U1011, F-59000 Lille, France; Institut Pasteur de Lille, F-59000 Lille, France; CHU Lille, Department of Cardiovascular Medicine, France.

François Pontana (F)

Univ. Lille, U1011 - EGID, F-59000 Lille, France; Inserm, U1011, F-59000 Lille, France; Institut Pasteur de Lille, F-59000 Lille, France; CHU Lille, Department of Cardiovascular Radiology, France.

Samy Aghezzaf (S)

CHU Lille, Department of Clinical Physiology and Echocardiography, France.

Florent Janvier (F)

CHU Lille, Department of Clinical Physiology and Echocardiography, France.

Stéphanie Mouton (S)

CHU Lille, Department of Clinical Physiology and Echocardiography, France.

Hélène Ridon (H)

CHU Lille, Department of Clinical Physiology and Echocardiography, France.

Staniel Ortmans (S)

CHU Lille, Department of Clinical Physiology and Echocardiography, France.

Claire Seunes (C)

CHU Lille, Department of Clinical Physiology and Echocardiography, France.

Marine Wautier (M)

CHU Lille, Department of Clinical Physiology and Echocardiography, France.

Amandine Coppin (A)

CHU Lille, Department of Clinical Physiology and Echocardiography, France.

Anne-Laure Madika (AL)

CHU Lille, Department of Clinical Physiology and Echocardiography, France.

Bertrand Boutie (B)

CHU Lille, Department of Clinical Physiology and Echocardiography, France.

Mohamad Koussa (M)

CHU Lille, Department of Cardiovascular Surgery, France.

Antoine Bical (A)

CHU Lille, Department of Cardiovascular Surgery, France.

André Vincentelli (A)

CHU Lille, Department of Cardiovascular Surgery, France.

Francis Juthier (F)

CHU Lille, Department of Cardiovascular Surgery, France.

Valentin Loobuyck (V)

CHU Lille, Department of Cardiovascular Surgery, France.

Arnaud Sudre (A)

CHU Lille, Department of Cardiovascular Medicine, France.

Stella Marchetta (S)

University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium; Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy.

Christophe Martinez (C)

University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium; Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy.

Bart Staels (B)

Univ. Lille, U1011 - EGID, F-59000 Lille, France; Inserm, U1011, F-59000 Lille, France; Institut Pasteur de Lille, F-59000 Lille, France; CHU Lille, Department of Biology, France.

Patrizio Lancellotti (P)

University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium; Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy.

Thomas Modine (T)

CHU Lille, Department of Cardiovascular Surgery, France.

David Montaigne (D)

CHU Lille, Department of Clinical Physiology and Echocardiography, France; Univ. Lille, U1011 - EGID, F-59000 Lille, France; Inserm, U1011, F-59000 Lille, France; Institut Pasteur de Lille, F-59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH